-
1
-
-
0027431788
-
The incidence of pleural effusion in a well-defined region. Epidemiologic study in central Bohemia
-
1 Marel M, Zrustova M, Stasny B et al. The incidence of pleural effusion in a well-defined region. Epidemiologic study in central Bohemia. Chest 1993;104:1486-9.
-
(1993)
Chest
, vol.104
, pp. 1486-1489
-
-
Marel, M.1
Zrustova, M.2
Stasny, B.3
-
2
-
-
0030827195
-
Malignant pleural effusion: Would the real cause please stand up?
-
2 Light RW, Hamm H. Malignant pleural effusion: would the real cause please stand up? Eur Respir J 1997;10:1701-2.
-
(1997)
Eur Respir J
, vol.10
, pp. 1701-1702
-
-
Light, R.W.1
Hamm, H.2
-
3
-
-
0026593331
-
Expression of vascular endothelial growth factor during angiogenesis and endothelial cell differentiation
-
3 Breier G, Albrecht U, Sterrer S, et al. Expression of vascular endothelial growth factor during angiogenesis and endothelial cell differentiation. Development 1992;114:521-32.
-
(1992)
Development
, vol.114
, pp. 521-532
-
-
Breier, G.1
Albrecht, U.2
Sterrer, S.3
-
4
-
-
0027104066
-
Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages and tumours
-
4 Berse B, Brown LF, Van de Water L, et al. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages and tumours. Mol Biol Cell 1992;3:211-20.
-
(1992)
Mol Biol Cell
, vol.3
, pp. 211-220
-
-
Berse, B.1
Brown, L.F.2
Van De Water, L.3
-
5
-
-
0029923104
-
Analysis of the tumour vasculature and metastatic behaviour of xenografts of human melanoma cell lines transfected with vascular permeability factor
-
5 Potgens AJ, van Altena MC, Lubsen NH, et al. Analysis of the tumour vasculature and metastatic behaviour of xenografts of human melanoma cell lines transfected with vascular permeability factor. Am J Pathol 148:1203-17.
-
Am J Pathol
, vol.148
, pp. 1203-1217
-
-
Potgens, A.J.1
Van Altena, M.C.2
Lubsen, N.H.3
-
6
-
-
0027213127
-
Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumour and inflammatory effusions
-
6 Yeo KT, Wang HH, Nagy JA, et al. Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumour and inflammatory effusions. Cancer Res 1993;53:2912-8.
-
(1993)
Cancer Res
, vol.53
, pp. 2912-2918
-
-
Yeo, K.T.1
Wang, H.H.2
Nagy, J.A.3
-
7
-
-
0003235007
-
Expression of vascular endothelial growth factor (VEGF) in malignant mesothelioma
-
7 Tolnay E, Wiethege JE, Konig C, et al. Expression of vascular endothelial growth factor (VEGF) in malignant mesothelioma. Eur Respir J 1997;10(Suppl 25):395s.
-
(1997)
Eur Respir J
, vol.10
, Issue.SUPPL. 25
-
-
Tolnay, E.1
Wiethege, J.E.2
Konig, C.3
-
8
-
-
0030005057
-
Interrelationships between microvessel density, expression of VEGF and resistance to doxorubicin of non-small cell carcinoma
-
8 Volm M, Koomagi R, Mattern J. Interrelationships between microvessel density, expression of VEGF and resistance to doxorubicin of non-small cell carcinoma. Anticancer Res 1996;16:213-7.
-
(1996)
Anticancer Res
, vol.16
, pp. 213-217
-
-
Volm, M.1
Koomagi, R.2
Mattern, J.3
-
9
-
-
0030756796
-
Vascular endothelial growth factor and its receptors correlate with angiogenesis and survival in pulmonary adenocarcinoma
-
9 Takanami I, Tanaka F, Hashizume T, et al. Vascular endothelial growth factor and its receptors correlate with angiogenesis and survival in pulmonary adenocarcinoma. Anticancer Res 1997;17(4A):2811-4.
-
(1997)
Anticancer Res
, vol.17
, Issue.4 A
, pp. 2811-2814
-
-
Takanami, I.1
Tanaka, F.2
Hashizume, T.3
-
10
-
-
1842328560
-
Prognostic value of vascular endothelial growth factor and its receptor FLT-1 in squamous cell lung cancer
-
10 Volm M, Koomagi R, Mattern J. Prognostic value of vascular endothelial growth factor and its receptor FLT-1 in squamous cell lung cancer. Int J Cancer 1997;74:64-8.
-
(1997)
Int J Cancer
, vol.74
, pp. 64-68
-
-
Volm, M.1
Koomagi, R.2
Mattern, J.3
-
11
-
-
0030842819
-
Human neutrophils secrete vascular endothelial growth factor
-
11 Taichmann NS, Young S, Cruchley A, et al. Human neutrophils secrete vascular endothelial growth factor. J Leukoc Biol 1997;62:397-400.
-
(1997)
J Leukoc Biol
, vol.62
, pp. 397-400
-
-
Taichmann, N.S.1
Young, S.2
Cruchley, A.3
-
12
-
-
0028216495
-
VPF/VEGF: Accumulation and expression in human synovial fluids and rheumatoid joint tissue
-
12 Fava RA, Olsen NJ, Spencer-Green G, et al. VPF/VEGF: accumulation and expression in human synovial fluids and rheumatoid joint tissue. J Exp Med 1994;18:341-6.
-
(1994)
J Exp Med
, vol.18
, pp. 341-346
-
-
Fava, R.A.1
Olsen, N.J.2
Spencer-Green, G.3
-
13
-
-
0028971747
-
A possible role of TGF-beta in the formation of malignant effusions
-
13 Ikubo A, Morisaki T, Katano M, et al. A possible role of TGF-beta in the formation of malignant effusions. Clin Immunol Immunopathol 1995;77:27-32.
-
(1995)
Clin Immunol Immunopathol
, vol.77
, pp. 27-32
-
-
Ikubo, A.1
Morisaki, T.2
Katano, M.3
-
14
-
-
0031415919
-
TNF-alpha causes reversible in vivo systemic vascular barrier dysfunction via NO-dependent and -independent mechanisms
-
14 Worrall NK, Chang K, LeJeune WS, et al. TNF-alpha causes reversible in vivo systemic vascular barrier dysfunction via NO-dependent and -independent mechanisms. Am J Physiol 1997;273:H2565-74.
-
(1997)
Am J Physiol
, vol.273
-
-
Worrall, N.K.1
Chang, K.2
LeJeune, W.S.3
-
15
-
-
0028834106
-
Pathogenesis of ascites tumour growth: Vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation
-
15 Nagy KA, Masse EM, Herzberg KT, et al. Pathogenesis of ascites tumour growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation. Cancer Res 1995;55:360-8.
-
(1995)
Cancer Res
, vol.55
, pp. 360-368
-
-
Nagy, K.A.1
Masse, E.M.2
Herzberg, K.T.3
-
17
-
-
0030983569
-
Bronchial vascular congestion and angiogenesis
-
17 Charan NB, Baile EM, Pare PD. Bronchial vascular congestion and angiogenesis. Eur Respir J 1997;10:1173-80.
-
(1997)
Eur Respir J
, vol.10
, pp. 1173-1180
-
-
Charan, N.B.1
Baile, E.M.2
Pare, P.D.3
-
18
-
-
1842366022
-
Intracellular pool of vascular endothelial growth factor in human neutrophils
-
18 Gaudry M, Bregerie O, Andrieu V, et al. Intracellular pool of vascular endothelial growth factor in human neutrophils. Blood 1997;90:4153-61.
-
(1997)
Blood
, vol.90
, pp. 4153-4161
-
-
Gaudry, M.1
Bregerie, O.2
Andrieu, V.3
-
19
-
-
4243351540
-
Vascular endothelial growth factor (VEGF) expression in human pulmonary epithelial cells: Upregulation by cytokines and hypoxia
-
19 Boussat S, Eddahibi S, Coste B, et al. Vascular endothelial growth factor (VEGF) expression in human pulmonary epithelial cells: upregulation by cytokines and hypoxia. Am J Respir Crit Care Med 1998;157:A354.
-
(1998)
Am J Respir Crit Care Med
, vol.157
-
-
Boussat, S.1
Eddahibi, S.2
Coste, B.3
-
20
-
-
0029004025
-
Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
-
20 Dvorak HF, Brown LF, Detmar M, et al. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995;146:1029-39.
-
(1995)
Am J Pathol
, vol.146
, pp. 1029-1039
-
-
Dvorak, H.F.1
Brown, L.F.2
Detmar, M.3
-
21
-
-
0030001058
-
The configuration of fibrin clots determines capillary morphogenesis and endothelial cell migration
-
21 Nehls V, Herrmann R. The configuration of fibrin clots determines capillary morphogenesis and endothelial cell migration. Microvasc Res 1996;51:347-64.
-
(1996)
Microvasc Res
, vol.51
, pp. 347-364
-
-
Nehls, V.1
Herrmann, R.2
-
22
-
-
0002853251
-
Angiogenesis antagonists: Current clinical trials
-
22 Brem S. Angiogenesis antagonists: current clinical trials. Angiogenesis 1998;2:9-20.
-
(1998)
Angiogenesis
, vol.2
, pp. 9-20
-
-
Brem, S.1
|